Developmental paediatric anaesthetic pharmacology

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Resumé

Safe and effective drug therapy in neonates, infants and children require detailed knowledge about the ontogeny of drug disposition and action as well how these interact with genetics and co-morbidity of children. Recent advances in developmental pharmacology in children follow the increased understanding of the impact of growth and development on drug disposition (ADME: absorption, distribution, metabolism and excretion). Numerous approaches have been used to determine optimal dosing of drugs in children, none of which are perfect. Human growth is a non-linear process and age-related changes in body composition and organ function are dynamic and often discordant during infancy. Major gaps of knowledge remain regarding the ontogeny of drug metabolizing enzymes and transporting proteins, and the paucity of pharmacodynamic and pharmacogenetic data in the paediatric population remains overwhelming.
OriginalsprogEngelsk
TidsskriftAnaesthesia and Intensive Care Medicine
Vol/bind16
Udgave nummer8
Sider (fra-til)417-422
ISSN1472-0299
DOI
StatusUdgivet - 2015

Bibliografisk note

0

Emneord

  • Drug metabolizing enzymes ontogeny paediatric pharmacology pharmacodynamics pharmacogenetics pharmacokinetics INFANTS PHARMACOKINETICS CHILDREN

Citer dette

@article{66c575b978bb47aa875ffa67566ea7f4,
title = "Developmental paediatric anaesthetic pharmacology",
abstract = "Safe and effective drug therapy in neonates, infants and children require detailed knowledge about the ontogeny of drug disposition and action as well how these interact with genetics and co-morbidity of children. Recent advances in developmental pharmacology in children follow the increased understanding of the impact of growth and development on drug disposition (ADME: absorption, distribution, metabolism and excretion). Numerous approaches have been used to determine optimal dosing of drugs in children, none of which are perfect. Human growth is a non-linear process and age-related changes in body composition and organ function are dynamic and often discordant during infancy. Major gaps of knowledge remain regarding the ontogeny of drug metabolizing enzymes and transporting proteins, and the paucity of pharmacodynamic and pharmacogenetic data in the paediatric population remains overwhelming.",
keywords = "Drug metabolizing enzymes ontogeny paediatric pharmacology pharmacodynamics pharmacogenetics pharmacokinetics INFANTS PHARMACOKINETICS CHILDREN",
author = "Hansen, {Tom Giedsing}",
note = "0",
year = "2015",
doi = "10.1016/j.mpaic.2015.06.004",
language = "English",
volume = "16",
pages = "417--422",
journal = "Anaesthesia and Intensive Care Medicine",
issn = "1472-0299",
publisher = "TheMedicine Publishing Company",
number = "8",

}

Developmental paediatric anaesthetic pharmacology. / Hansen, Tom Giedsing.

I: Anaesthesia and Intensive Care Medicine, Bind 16, Nr. 8, 2015, s. 417-422.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - Developmental paediatric anaesthetic pharmacology

AU - Hansen, Tom Giedsing

N1 - 0

PY - 2015

Y1 - 2015

N2 - Safe and effective drug therapy in neonates, infants and children require detailed knowledge about the ontogeny of drug disposition and action as well how these interact with genetics and co-morbidity of children. Recent advances in developmental pharmacology in children follow the increased understanding of the impact of growth and development on drug disposition (ADME: absorption, distribution, metabolism and excretion). Numerous approaches have been used to determine optimal dosing of drugs in children, none of which are perfect. Human growth is a non-linear process and age-related changes in body composition and organ function are dynamic and often discordant during infancy. Major gaps of knowledge remain regarding the ontogeny of drug metabolizing enzymes and transporting proteins, and the paucity of pharmacodynamic and pharmacogenetic data in the paediatric population remains overwhelming.

AB - Safe and effective drug therapy in neonates, infants and children require detailed knowledge about the ontogeny of drug disposition and action as well how these interact with genetics and co-morbidity of children. Recent advances in developmental pharmacology in children follow the increased understanding of the impact of growth and development on drug disposition (ADME: absorption, distribution, metabolism and excretion). Numerous approaches have been used to determine optimal dosing of drugs in children, none of which are perfect. Human growth is a non-linear process and age-related changes in body composition and organ function are dynamic and often discordant during infancy. Major gaps of knowledge remain regarding the ontogeny of drug metabolizing enzymes and transporting proteins, and the paucity of pharmacodynamic and pharmacogenetic data in the paediatric population remains overwhelming.

KW - Drug metabolizing enzymes ontogeny paediatric pharmacology pharmacodynamics pharmacogenetics pharmacokinetics INFANTS PHARMACOKINETICS CHILDREN

U2 - 10.1016/j.mpaic.2015.06.004

DO - 10.1016/j.mpaic.2015.06.004

M3 - Review

VL - 16

SP - 417

EP - 422

JO - Anaesthesia and Intensive Care Medicine

JF - Anaesthesia and Intensive Care Medicine

SN - 1472-0299

IS - 8

ER -